On March 20, 2024, Ramesh Kumar, PhD, a member of the board of directors since 2019 notified Ocugen, Inc. that he will not stand for re-election as a director of the Company upon the expiration of his current term, which expires at the Company?s 2024 Annual Meeting of Stockholders. Class I directors of the Board of Directors, of which Mr. Kumar is a member, terms expire at the Annual Meeting and are up for re-election at the Annual Meeting. Dr. Kumar?s refusal to stand for re-election was not the result of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | -1.73% | -2.86% | +195.65% |
May. 31 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
May. 31 | Ocugen Gets Recommendation For Dose Escalation in Eye Disease Trial; Shares Climb | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+195.65% | 445M | |
+48.64% | 54.63B | |
-6.44% | 39.92B | |
+37.07% | 38.82B | |
+14.28% | 26.86B | |
-11.17% | 26.22B | |
-21.40% | 18.78B | |
+25.64% | 12.21B | |
+0.96% | 12.16B | |
+27.04% | 11.94B |
- Stock Market
- Equities
- OCGN Stock
- News Ocugen, Inc.
- Ocugen, Inc. Announces Ramesh Kumar Will Not Stand for Re-Election as Director